相关实验视频
Updated: Jul 16, 2026

05:17
Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
58.8K
避免刺痛:儿科患者静脉输入 olanzapine 的病例系列
Abdiweli Hassan1, Mike Raschka2
1College of Pharmacy (AH), Midwestern University, Glendale, AZ.
概括
静脉输入的奥兰扎平对儿科重症监护病房的患者来说是有前途的. 这项研究发现,当其他途径不可行时,IV奥兰扎在重症儿童的痴呆症,恶心和吐中是安全和有效的.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科重症监护 儿科重症监护
- 精神病学是一个精神病学.
背景情况:
- 奥兰沙平已被批准用于精神疾病,但显示出ICU相关的痴呆症,恶心和吐的潜力.
- 目前的注射途径 (肌内和肠道) 限制了儿科患者的使用,特别是那些NPO (无口服) 或重症监护机构的使用.
- 在成年人中,静脉注射 (IV) olanzapine 已经证明了其安全性和有效性.
研究的目的:
- 评估小儿科患者静脉注射 olanzapine 的安全性和疗效.
- 在无法接受肌内或肠道药物治疗的儿科患者中,探索奥兰扎宾的替代性施用途径.
主要方法:
- 4名儿科患者的病例系列,他们至少接受了一剂IV olanzapine.
- 对不良事件的监测和评估治疗反应.
主要成果:
- 所有4名儿科患者都对IV奥兰zapine产生了积极反应.
- 在输入式 olanzapine 的使用过程中,没有发现安全问题.
结论:
- 静脉注射 olanzapine 似乎是一个安全和有效的选择,在重症监护机构的儿科患者.
- 这种途径为那些无法通过肌内或肠道途径接受 olanzapine 的儿科患者提供了可行的替代方案.
相关概念视频
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

